Role of SIRT1 and Progesterone Resistance in Normal and Abnormal Endometrium
- 19 October 2021
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (3), 788-800
- https://doi.org/10.1210/clinem/dgab753
Abstract
Context Progesterone resistance, a known pathologic condition associated with a reduced cellular response to progesterone and heightened estrogen responses, appears to have a normal physiologic role in mammalian reproduction. The molecular mechanism responsible for progesterone resistance in normal and abnormal endometrium remains unclear. Objective To examine the roles of Sirtuin-1 (SIRT1) in normal endometrium as well as endometrium associated with infertility and endometriosis, as an epigenetic modulator associated with progesterone resistance. Methods SIRT1 expression was examined by Western blot, RT-qPCR and immunohistochemistry in mouse uterus and human endometrium. Mice with uterine specific Sirt1 overexpression were developed to examine SIRT1’s role in endometrial function and endometriosis development. EX-527, a SIRT1 inhibitor, and SRT1720, a SIRT1 agonist, were also used to evaluate SIRT1 effect on endometriosis. Results In normal healthy women, endometrial SIRT1 is expressed only during menses. SIRT1 was dramatically overexpressed in the endometrium from women with endometriosis in both the epithelium and strom. In mice, SIRT1 is expressed at the time of implantation between day 4.5 and 5.5 of pregnancy. Overexpression of SIRT1 (Sirt1 over) in the mouse uterus leads to subfertility due to implantation failure and decidualization defects and progesterone resistance. SIRT1 overexpression in endometriotic lesion promotes worsening endometriosis development. EX-527 (SIRT1 inhibitor) significantly reduced the number of endometriotic lesions in the mouse endometriosis model. Conclusions SIRT1 expression and progesterone resistance appears to play -roles in normal endometrial functions. Aberrant SIRT1 expression contributes to progesterone resistance and may participate in the pathophysiology of endometriosis. SIRT1 is a novel and targetable protein for the diagnosis as well as treatment of endometriosis and the associated infertility seen in this disease.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institutes of Health (R01HD084478, R01HD101243, R01HD102170, P01HD106485)
This publication has 62 references indexed in Scilit:
- The progesterone receptor regulates implantation, decidualization, and glandular development via a complex paracrine signaling networkMolecular and Cellular Endocrinology, 2012
- Inflammatory pathways in endometrial disordersMolecular and Cellular Endocrinology, 2011
- Mammalian Sirt1: insights on its biological functionsCell Communication and Signaling, 2011
- Implantation failure: molecular mechanisms and clinical treatmentHuman Reproduction Update, 2010
- EndometriosisThe New England Journal of Medicine, 2010
- Role of laparoscopic treatment of endometriosis in patients with failed in vitro fertilization cyclesFertility and Sterility, 2005
- Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinomaThe Journal of Pathology, 2005
- Cre-mediated recombination in cell lineages that express the progesterone receptorgenesis, 2005
- Blastocyst implantation depends on maternal expression of leukaemia inhibitory factorNature, 1992
- Vascular and cellular changes in the decidualized endometrium of the ovariectomized mouse following cessation of hormone treatment: a possible model for menstruationJournal of Endocrinology, 1984